Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2025-12-25 @ 11:37 PM
NCT ID: NCT02694393
Description: The adverse events predicted to be of interest were: methemoglobinemia, hypotension and bronchoconstriction (as measured by FEV1)
Frequency Threshold: 0
Time Frame: Up to 42 days following first drug administration visit
Study: NCT02694393
Study Brief: Inhaled Sodium Nitrite as an Antimicrobial for Cystic Fibrosis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Nebulized Nitrite 40-80 mg nebulized nitrite administration 0 None 0 2 2 2 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Methemoglobinemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Hypotension NON_SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Decreased FEV1 NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View